Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cogent Biosciences (COGT) Shares Outstanding (Weighted Average) (2017 - 2021)

Historic Shares Outstanding (Weighted Average) for Cogent Biosciences (COGT) over the last 5 years, with Q3 2021 value amounting to $39.8 million.

  • Cogent Biosciences' Shares Outstanding (Weighted Average) rose 30453.6% to $39.8 million in Q3 2021 from the same period last year, while for Sep 2021 it was $39.8 million, marking a year-over-year increase of 30453.6%. This contributed to the annual value of $11.1 million for FY2020, which is 4542.18% up from last year.
  • Cogent Biosciences' Shares Outstanding (Weighted Average) amounted to $39.8 million in Q3 2021, which was up 30453.6% from $38.4 million recorded in Q2 2021.
  • Cogent Biosciences' Shares Outstanding (Weighted Average)'s 5-year high stood at $39.8 million during Q3 2021, with a 5-year trough of $7.5 million in Q1 2020.
  • For the 5-year period, Cogent Biosciences' Shares Outstanding (Weighted Average) averaged around $19.0 million, with its median value being $10.2 million (2018).
  • Its Shares Outstanding (Weighted Average) has fluctuated over the past 5 years, first plummeted by 7495.53% in 2020, then soared by 39426.93% in 2021.
  • Over the past 5 years, Cogent Biosciences' Shares Outstanding (Weighted Average) (Quarter) stood at $10.2 million in 2017, then soared by 144.27% to $24.9 million in 2018, then crashed by 69.39% to $7.6 million in 2019, then skyrocketed by 45.42% to $11.1 million in 2020, then soared by 259.61% to $39.8 million in 2021.
  • Its Shares Outstanding (Weighted Average) stands at $39.8 million for Q3 2021, versus $38.4 million for Q2 2021 and $34.9 million for Q1 2021.